Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsy

Anja Van Campenhout*, Lynn Bar-On, Kaat Desloovere, Guy Molenaers

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Botulinum toxin type A (BTX) injections are frequently used in children with cerebral palsy (CP) to control spasticity. Injection variables still lead to variable outcomes of this treatment. Using instrumented spasticity assessment and muscle volume assessment the most effective location of the injection was demonstrated for gracilis and psoas muscles in children with CP. It was found that this treatment is most effective when injected in the motor endplate zones of the selected muscles. This review article presents all available research on the role of motor endplate-targeting of BTX injections in children with CP.

Original languageEnglish
Pages (from-to)167-171
Number of pages5
JournalActa Orthopaedica Belgica
Volume81
Issue number2
Publication statusPublished - 1 Jan 2015

Cite this